20924 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals Cationic antimicrobial peptides, e.g. defensins
ß-DEFENSIN-2 PEPTIDE FOR INHIBITING CELL GROWTH OF COLON CANCER
#2DIELS-ALDER CONJUGATION METHODS
#3PLANT-DERIVED COMPOSITIONS THAT MODULATE CELLULAR IMMUNITY
#4ANTIMICROBIAL THERAPY
#5IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#6Synergistic antimicrobial compositions containing selected peptides and fatty acids
#7COMBINATION, THERAPEUTIC USES AND PROPHYLACTIC USES
#8COMPOSITIONS AND METHODS FOR ACTIVATING INNATE IMMUNITY
#9APPLICATION OF CAERIN 1.1/1.9 COMBINED WITH ANTI-CD47 ANTIBODY IN PREPARING DRUG FOR TREATING MELANOMA
#10ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF
#11ANTIVIRAL PEPTIDES AND METHODS OF USE THEREOF
#12PLANT-DERIVED COMPOSITIONS THAT MODULATE CELLULAR IMMUNITY
#13Prophylactic Uses of Theta Defensins
#14MATURATION OF MUCOSAL DEFENSE AND GUT/LUNG FUNCTION IN THE PRETERM INFANT
#15COMPOSITIONS AND METHODS FOR TREATMENTS BY MODULATION OF EXCITABLE TISSUES ACTIVITIES, AND FOR ANTIMICROBIAL APPLICATIONS
#16ANTIMICROBIAL MATRIX FORMED FROM PEPTIDE HYDROGELS
#17COMPOSITIONS AND METHODS FOR TREATING MASTITIS
#18METHOD FOR PREVENTION OR TREATMENT OF DISEASES CAUSED BY PATHOGEN-ASSOCIATED MOLECULAR PATTERN
#19RNA STABILIZING NANOPARTICLES
#20COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF
#21Methods for Enhancing Immune Checkpoint Inhibitor Therapy
#22Immune checkpoint inhibitor combinations
#23DIELS-ALDER CONJUGATION METHODS
#24CATIONIC ANTIMICROBIAL PEPTIDES AND USES THEREOF
#25Compositions Comprising Antimicrobial Peptides
#26CATH2 AND DERIVATIVES FOR INHIBITING STREPTOCOCCUS SUIS
#27PEPTIDE COMPOUNDS AND METHODS OF USE
#28Oral Composition and Methods
#29COMPOSITIONS AND METHODS OF USE OF SYNTHETIC PEPTIDES WITH MYCOBACTERIUM ABSCESSUS INHIBITORY ACTIVITY
#30CATH2 DERIVATIVES FOR STIMULATING INNATE IMMUNE MEMORY
#31METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE-MEDIATED DISEASES
#32METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS
#33ANTIMICROBIAL BIOSENSORS
#34HYDROXYSTEARIC ACID FOR INDUCING GENERATION OF ANTIMICROBIAL PEPTIDES
#35COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF
#36Co-agents as Therapy Against Anaerobic Pathogens
#37Dermal Patch for Transdermal Modulation of Ghrelin Pathway
#38METHOD OF ENCAPSULATION OF AN ACTIVE PROTEIN USING ELECTRODEPOSITION TECHNIQUES, AN ANTIBACTERIAL COMPOSITION CONTAINING THE ACTIVE PROTEIN AND A POLYMER, AND ITS USE FOR THE PRODUCTION OF MEDICATIONS INTENDED FOR HUMANS
#39METHOD FOR TREATMENT OF TYPE-1 DIABETES IN A SUBJECT IN NEED THEREOF
#40IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#41COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND METHODS OF USE THEREOF
#42ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF
#43METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS
#44PENTAPEPTIDE AND METHODS OF USE THEREOF
#45HISTATIN-1 FORMULATION FOR THE TREATMENT, REPAIR OR REGENERATION OF BONE TISSUE IN A SUBJECT
#46Diels-alder conjugation methods
#47NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS
#48Compositions and methods of use of synthetic peptides with inhibitory activity
#49POTENTIATORS OF ANTIMICROBIAL AND/OR ANTIVIRAL AGENTS
#50Compositions comprising antimicrobial peptides
#51ANTIMICROBIAL THERAPY THROUGH THE COMBINATION OF PORE-FORMING AGENTS AND HISTONES
#52USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS
#53Compositions and methods for skin rejuvenation
#54XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF
#55TREATMENT OF SYNUCLEINOPATHY AND ANIMAL MODELS OF SYNUCLEINOPATHY
#56Peptide compounds and methods of use in wound healing
#57Compositions comprising antimicrobial peptides
#58ANTIMICROBIAL BIOPOLYMER COMPOSITIONS, METHODS OF SYNTHESIS, AND APPLICATIONS OF USE
#59Zinc Porters, and their Monoclonal Antibody Conjugates, for the Prevention and Treatment of COVID-19 (SARS-CoV-2), Other Infections, and Cancers
#60IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#61METHODS OF USING HISTATIN FOR DIAGNOSING AND TREATING A DRY EYE DISEASE OR OTHER OCULAR DISEASES
#62Antibody molecule-drug conjugates and uses thereof
#63Compositions and related methods for controlling vector-borne diseases
#64Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with same
#65Stem cell stimulating compositions for treatment of melasma
#66Antimicrobial therapy
#67Treatment of chronic ulcers
#68Compositions and methods for treatment of protease mediated disease
#69MATURATION OF MUCOSAL DEFENSE AND GUT/LUNG FUNCTION IN THE PRETERM INFANT
#70Oral composition and method
#71COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES
#72Balance shaft having reduced mass and inertia
#73Antimicrobial therapy
#74STABILIZED ANTI-MICROBIAL PEPTIDES
#75PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF
#76COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES
#77RECOMBINANT BACULOVIRUSES AND USES THEREOF
#78Methods for treating inflammatory conditions of the lungs
#79AGENTS AND METHODS FOR TREATMENT OF PATHOGENS
#80Treatment of chronic ulcers
#81Treatment of liver, biliary tract and pancreatic disorders
#82INHIBITION OF BIOFILM ORGANISMS
#83METHODS FOR MODULATING INTESTINAL MICROBIOTA
#84Antibacterial and antifungal compounds
#85Use of dermcidin in sterile inflammatory conditions
#86Stem cell stimulating compositions and methods of treating melasma
#87Antimicrobial composition
#88Compositions and methods for sensitizing low responsive tumors to cancer therapy
#89Sprayable topical carrier and composition comprising phosphatidylcholine
#90ANTIMICROBIAL THERAPY
#91Engineered nucleic acids and methods of use thereof
#92Immune checkpoint inhibitor combinations
#93Peptide Compounds and Methods of Production and Use Thereof
#94DNA PLASMID, CODING HNP-1, OR HNP-2, OR HNP-3, BACTERIAL PRODUCER, ANALGESIC AGENT (VARIANTS)
#95Sprayable Topical Carrier and Composition Comprising Phosphatidylcholine
#96Method for treating microbial infection
#97DISINFECTANT AND ANTIMICROBIAL COMPOSITIONS, IN PARTICULAR FOR THE VETERINARY FIELD
#98SHORT BETA-DEFENSIN-DERIVED PEPTIDES
#99Peptide antagonist of LL-37
#100Peptide Compounds and Methods of Production and Use Thereof
#101Engineered nucleic acids and methods of use thereof
#102Agents and methods for treatment of pathogens
#103Compositions and Methods for Inhibiting Pro-Inflammatory Cytokine Gene Expression
#104Stabilized anti-microbial peptides
#105Granulysin in immunotherapy
#106Peptide Compounds and Methods of Production and Use Thereof
#107Sprayable topical carrier and composition comprising phosphatidylcholine
#108Compositions and method for treatment of inflammatory bowel disease
#109Treatment of chronic ulcers
#110Lipid nanoparticles for wound healing
#111Oral treatment of inflammatory bowel disease
#112Short beta-defensin-derived peptides
#113Peptide compounds and methods of production and use thereof
#114Recombinant Escherichia Coli Strains
#115DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDES OR THEIR INHIBITORS
#116Engineered nucleic acids and methods of use thereof
#117Granulysin in immunotherapy
#118METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN
#119Therapeutic agent for infections, and treatment method using same
#120Disease treatment via antimicrobial peptides or their inhibitors
#121Oral treatment of inflammatory bowel disease
#122Anticaries compositions and probiotics/prebiotics
#123Treatment of inflammatory bowel diseases with mammal beta defensins
#124Antimicrobial lytic peptides
#125Use of peptides for promoting wound healing
#126MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES
#127Method for inducing lymphoid tissue and modulating intestinal homeostasis
#128Use of peptides for promoting wound healing
#129METHODS OF TREATING AND PREVENTING RHINOVIRUS INFECTION
#130ORAL TREATMENT OF INFLAMMATORY BOWEL DISEASE
#131Blockade of inflammatory proteases with cyclic peptides
#132Therapeutic Agent for infections, and treatment method using the same
#133INHIBITORS OF LL-37 MEDIATED IMMUNE REACTIVITY TO SELF NUCLEIC ACIDS
#134Treatment of Rheumatoid Arthritis With Mammal Beta Defensins
#135Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins
#136Disease treatment via antimicrobial peptides or their inhibitors
#137Natural polypeptides for oral health care
#138Granulysin in immunotherapy
#139Inhibition of biofilm organisms
#140Method for the treatment of pulmonary disease and method of producing proteins of use therein
#141Pharmaceutical Compositions Containing Antifungal Peptides
#142Short beta-defensin-derived peptides
#143Treatment of inflammatory bowel diseases with mammal beta defensins
#144Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia
#145Use of peptides for promoting wound healing
#146METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS
#147C-Terminal Ifapsoriasin Fragments as Antimicrobial Peptides, the Production Thereof and Use Thereof
#148Method for inducing lymphoid tissue and modulating intestinal homeostasis
#149USE OF A DEFENSIN PEPTIDE AS A THERAPEUTIC AGENT
#150Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#151USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#152SELECTIVELY TARGETED ANTIMICROBIALS FOR THE TREATMENT OF PERIODONTAL DISEASE
#153METHODS AND COMPOSITION FOR USE OF CYCLIC ANALOGUES OF HISTATIN
#154Natural polypeptides for oral health care
#155Antimicrobial peptides
#156TARGETED BIOCIDES
#157Treatment Of Inflammatory Diseases With Mammal Beta Defensins
#158Treatment of rheumatoid arthritis with mammal beta defensins
#159Treatment of inflammatory bowel diseases with mammal beta defensins
#160Therapeutic agent for infections, and treatment method using the same
#161USE OF DEFENSINS AGAINST MENINGITIS
#162Immunodynamic complexes and methods for using and preparing such complexes
#163Surface-layer protein coated microspheres and uses thereof
#164Disease treatment via antimicrobial peptides or their inhibitors
#165USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#166Biocides
#167Immunologic regulation by theta defensins
#168AGENT FOR PROMOTING OSTEOGENESIS AND/OR INHIBITING BONE RESORPTION
#169Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins
#170USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
#171Targeted biocides
#172Biomarkers of resistance to infections in humans and biological applications thereof
#173Agent for promoting osteogenesis and/or inhibiting bone resorption
#174Mucoadhesive composition comprising polyacrylate and chemoattractant
#175Methods for increasing cell and tissue viability
#176Biocides
#177Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
#178Immunodynamic complexes and methods for using and preparing such complexes
#179Immunodynamic complexes and methods for using and preparing such complexes
#180Chicken cathelicidins as a cancer therapy